Found: 12
Select item for more details and to access through your institution.
PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 Trial.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 1, p. 175, doi. 10.1245/s10434-021-10505-0
- By:
- Publication type:
- Article
A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non–small-cell Lung Cancer: SWOG 1206 (8811).
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 313, doi. 10.1016/j.cllc.2021.02.009
- By:
- Publication type:
- Article
Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-23171-3
- By:
- Publication type:
- Article
Germline mutations and age at onset of lung adenocarcinoma.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 15, p. 2801, doi. 10.1002/cncr.33573
- By:
- Publication type:
- Article
Randomized phase 2 trial of erlotinib in combination with high-dose celecoxib or placebo in patients with advanced non-small cell lung cancer.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 18, p. 3298, doi. 10.1002/cncr.29480
- By:
- Publication type:
- Article
Phase II Trial of Cabozantinib Plus Erlotinib in Patients With Advanced Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer With Progressive Disease on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A California Cancer Consortium Phase II Trial (NCI 9303)
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00132
- By:
- Publication type:
- Article
A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors.
- Published in:
- BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-20
- By:
- Publication type:
- Article
A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Intravenous 5-fluoro-2'-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A phase I trial of topotecan plus tivantinib in patients with advanced solid tumors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Family Caregiver Preparedness: Developing an Educational Intervention for Symptom Management.
- Published in:
- Clinical Journal of Oncology Nursing, 2022, v. 26, n. 2, p. 165, doi. 10.1188/22.CJON.165-175
- By:
- Publication type:
- Article